NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.510
+0.120 (8.63%)
Mar 31, 2025, 2:34 PM EDT - Market open
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $2.45 million as of March 31, 2025. Its market cap has decreased by -77.87% in one year.
Market Cap
2.45M
Enterprise Value
3.27M
1-Year Change
-77.87%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $2.45M, a decrease of -87.82%. That is a compound annual growth rate of -39.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.11M | -38.39% |
| Dec 31, 2024 | 3.42M | -82.11% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |